IHC-plus(TM) Monoclonal Rat anti-Human CD209 / DC-SIGN Antibody (clone h209, IHC) LS-B3782

Artikelnummer: LS-B3782-50
Artikelname: IHC-plus(TM) Monoclonal Rat anti-Human CD209 / DC-SIGN Antibody (clone h209, IHC) LS-B3782
Artikelnummer: LS-B3782-50
Hersteller Artikelnummer: LS-B3782-50
Alternativnummer: LS-B3782-50
Hersteller: LifeSpan Biosciences
Wirt: Rat
Kategorie: Antikörper
Applikation: FC, IHC, IHC-P, IP
Spezies Reaktivität: Human
Immunogen: Human CD209
Konjugation: Unconjugated
Alternative Synonym: CD209, CD209 antigen, CD209 molecule, CDSIGN, CLEC4L, DC-SIGN, HIV gpl20-binding protein, DC-SIGN1
DC-SIGN antibody LS-B3782 is an unconjugated rat monoclonal antibody to human DC-SIGN (CD209). Validated for Flow, IHC and IP. Tested on 20 paraffin-embedded human tissues. Cited in 1 publication.
Klonalität: Monoclonal
Konzentration: 0.5 mg/ml
Klon-Bezeichnung: [h209]
NCBI: 30835
Puffer: Aqueous buffer, 0.09% sodium azide, may contain carrier protein/stabilizer.
Reinheit: Affinity purified
Formulierung: Aqueous buffer, 0.09% sodium azide, may contain carrier protein/stabilizer.
Application Verdünnung: Flo, IHC, IHC-P (20 µg/ml), IP
Anwendungsbeschreibung: Immunohistochemistry: LS-B3782 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody